These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multicenter institutional experience of surgically resected thymic epithelial tumors (TETs): an observational report on behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone). Genestreti G, Ampollini L, Burgio MA, Rolli L, Sanna S, Scarpi E, Monti M, Burgio SL, Giannone L, Santo A, Mezzetti M, Casanova C, Buosi R, Rusca M, Amadori D, Gavelli G. Ann Surg Oncol; 2013 Sep; 20(9):2958-63. PubMed ID: 23709100 [Abstract] [Full Text] [Related]
3. Treatment strategy and prognostic analysis of spinal metastases from thymomas: A retrospective study from a single center. Liu S, Zhou X, Song A, Huo Z, Yao S, Wang Y, Liu Y. Clin Neurol Neurosurg; 2020 Sep; 196():106056. PubMed ID: 32622111 [Abstract] [Full Text] [Related]
11. Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors. Johnson GB, Aubry MC, Yi ES, Koo CW, Jenkins SM, Garces YI, Marks RS, Cassivi SD, Roden AC. J Thorac Oncol; 2017 Feb; 12(2):354-367. PubMed ID: 27666658 [Abstract] [Full Text] [Related]
12. Outcomes and Safety Analysis in Superior Vena Cava Resection for Extended Thymic Epithelial Tumors. Bertolaccini L, Prisciandaro E, Galetta D, Casiraghi M, Guarize J, Petrella F, Sedda G, Lo Iacono G, Brambilla D, Spaggiari L. Ann Thorac Surg; 2021 Jul; 112(1):271-277. PubMed ID: 33068543 [Abstract] [Full Text] [Related]
13. Thymoma-a clinico-pathological long-term study with emphasis on histology and adjuvant radiotherapy dose. Harnath T, Marx A, Ströbel P, Bölke E, Willers R, Gripp S. J Thorac Oncol; 2012 Dec; 7(12):1867-1871. PubMed ID: 23154559 [Abstract] [Full Text] [Related]
14. Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression. Banna GL, Sheel A, Sheel V, Bille A, Routledge T, Fernando S, Nair A, Lal R. Future Oncol; 2017 Nov; 13(27):2429-2439. PubMed ID: 29121777 [Abstract] [Full Text] [Related]
15. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis. Janik S, Bekos C, Hacker P, Raunegger T, Ghanim B, Einwallner E, Beer L, Klepetko W, Müllauer L, Ankersmit HJ, Moser B. Oncotarget; 2017 Jul 18; 8(29):47090-47102. PubMed ID: 28514756 [Abstract] [Full Text] [Related]
16. Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study. Aisner SC, Dahlberg S, Hameed MR, Ettinger DS, Schiller JH, Johnson DH, Aisner J, Loehrer PJ. J Thorac Oncol; 2010 Jun 18; 5(6):885-92. PubMed ID: 20421818 [Abstract] [Full Text] [Related]
17. Induction therapy followed by surgical resection in Stage-III thimic epithelial tumors: Long-term results from a multicentre analysis of 108 cases. Cardillo G, Lucchi M, Marulli G, Infante M, Leuzzi G, Mussi A, Carleo F, Facciolo F, Voulaz E, Rea F, Rapicetta C, Lococo F. Lung Cancer; 2016 Mar 18; 93():88-94. PubMed ID: 26898620 [Abstract] [Full Text] [Related]
18. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis. Feng Y, Lei Y, Wu X, Huang Y, Rao H, Zhang Y, Wang F. Lung Cancer; 2017 Aug 18; 110():48-52. PubMed ID: 28676218 [Abstract] [Full Text] [Related]
19. Long-term survival in thymic epithelial tumors: a single-center experience from China. Shen S, Ai X, Lu S. J Surg Oncol; 2013 Feb 18; 107(2):167-72. PubMed ID: 22996015 [Abstract] [Full Text] [Related]
20. Small molecule multitarget antiangiogenic inhibitor treatments for advanced thymic epithelial tumors: A retrospective study. Shen W, Jin Y, Yu Y, Chen N, Fan Y. Thorac Cancer; 2024 Jan 18; 15(2):122-130. PubMed ID: 38011005 [Abstract] [Full Text] [Related] Page: [Next] [New Search]